Commentary on Grebely et al. (2019): Ending HCV epidemics among people who inject drugs.

The new direct-acting antiretroviral drugs for treating hepatitis C have generated considerable momentum for treating HCV infection among people who inject drugs and perhaps‘ ending the HCV epidemic’. There are, however, important epidemiological and behavior research problems that need to be addressed before‘ ending the HCV epidemic’ will be possible. [ABSTRACT FROM AUTHOR]